Web CRG
  1. Home
  2. Industry & Investors
  3. License CRG Technologies
  4. Technology Publisher

License CRG Technologies

Explore our Technology Portfolio

If you are exploring licensing opportunities at the CRG, the TBDO can guide you to a wide range of suitable researchers and their technologies.

Search Results - fatima+gebauer

1 Results Sort By:
Novel RNA Binding Protein Targets to Treat Melanoma
Figure 1. RNA-binding proteins as novel oncological targets. (A) Unbiased screen on cell lines with increasing cancer aggressiveness​. (B) Specific inhibition of the RNA binding domain of one of the hit candidate RBPs affects tumoral cells viability. Novel antitumoral RNA-binding protein targets in melanoma identified by an unbiased screen. We are...
Published: 10/28/2024   |   Inventor(s): Fatima Gebauer, Neus Mestre Farras, Santiago Guerrero
Keywords(s): Melanoma, Oncology
Category(s): Drug Targets & Mechanisms, Therapeutics (Biologics & Compounds)

 

 

Categories

Featured Technologies

Most Popular Keywords

Latest Technologies Published

Search our database for an up-to-date listing of CRG intellectual property available for licensing